BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29113452)

  • 1. Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.
    Altes P; Perez P; Esteban C; Sánchez Muñoz-Torrero JF; Aguilar E; García-Díaz AM; Álvarez LR; Jiménez PE; Sahuquillo JC; Monreal M;
    Angiology; 2018 Jul; 69(6):507-512. PubMed ID: 29113452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia and Outcome in Outpatients With Peripheral Artery Disease.
    Perez P; Esteban C; Caballero PE; Muñoz-Torrero JF; Soria MT; Aguilar E; Rodríguez LR; Sahuquillo JC; Díaz AM; Monreal M;
    Angiology; 2016 May; 67(5):484-9. PubMed ID: 26271128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol consumption and outcome in stable outpatients with peripheral artery disease.
    Garcia-Diaz AM; Marchena PJ; Toril J; Arnedo G; Muñoz-Torrero JF; Yeste M; Aguilar E; Monreal M;
    J Vasc Surg; 2011 Oct; 54(4):1081-7. PubMed ID: 21684714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease.
    Sanchez Muñoz-Torrero JF; Rico-Martín S; Álvarez LR; Aguilar E; Alcalá JN; Monreal M;
    Atherosclerosis; 2018 Sep; 276():10-14. PubMed ID: 30006322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol and outcome in outpatients with peripheral artery disease.
    Perez P; Esteban C; Sauquillo JC; Yeste M; Manzano L; Mujal A; Jiménez Caballero PE; Aguilar E; Sánchez Muñoz-Torrero JF; Monreal M;
    Thromb Res; 2014 Aug; 134(2):331-5. PubMed ID: 24951338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
    Muñoz-Torrero JFS; Zamorano J; Rico-Martín S; Rivas MD; Bacaicoa MA; Robles R; Sanchez-Bacaicoa C; Monreal M;
    Atherosclerosis; 2020 Jan; 292():84-89. PubMed ID: 31785493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of outcome in stable outpatients with peripheral artery disease.
    Sanclemente C; Yeste M; Suarez C; Coll R; Aguilar E; Sahuquillo JC; Lerma R; Monreal M;
    Intern Emerg Med; 2014 Feb; 9(1):69-77. PubMed ID: 23054402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease.
    Bernaudo D; Coll R; Sánchez Muñoz-Torrero JF; Pascual MT; García-Díaz AM; Alvarez LR; Monreal M;
    Atherosclerosis; 2013 Jul; 229(1):258-62. PubMed ID: 23714334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
    Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
    Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
    Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
    JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
    Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
    J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
    Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
    Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation.
    Aguilar E; García-Díaz AM; Sánchez Muñoz-Torrero JF; Alvarez LR; Piedecausa M; Arnedo G; Monreal M;
    Thromb Res; 2012 Sep; 130(3):390-5. PubMed ID: 22658293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).
    Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C;
    Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systolic Blood Pressure and Outcomes in Stable Outpatients with Recent Symptomatic Artery Disease: A Population-Based Longitudinal Study.
    Sánchez Muñoz-Torrero JF; Escudero-Sánchez G; Calderón-García JF; Rico-Martín S; Robles NR; Bacaicoa MA; Alcalá-Pedrajas JN; Gil-Fernández G; Monreal M; On Behalf Of The Frena Investigators
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.